Corvus hawaiiensis isolate bCorHaw1 chromosome 17, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036362.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
ERGIC and golgi 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ERGIC and golgi 3, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
ERGIC and golgi 3, transcript variant X2
endoplasmic reticulum-Golgi intermediate compartment protein 3 isoform X1
endoplasmic reticulum-Golgi intermediate compartment protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
fer-1-like protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fer-1-like protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fer-1-like protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RNA binding motif protein 39, transcript variant X2
RNA binding motif protein 39, transcript variant X1
RNA binding motif protein 39, transcript variant X4
RNA binding motif protein 39, transcript variant X3
RNA binding motif protein 39, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
RNA binding motif protein 39, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rho GTPase-activating protein 39-like, transcript variant X2
rho GTPase-activating protein 39-like isoform X2
rho GTPase-activating protein 39-like, transcript variant X1
rho GTPase-activating protein 39-like isoform X1
fibrous sheath interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibrous sheath interacting protein 2, transcript variant X1
fibrous sheath-interacting protein 2 isoform X2
fibrous sheath-interacting protein 2 isoform X1
PHD finger protein 20, transcript variant X2
PHD finger protein 20, transcript variant X5
PHD finger protein 20, transcript variant X7
PHD finger protein 20, transcript variant X10
PHD finger protein 20, transcript variant X11
PHD finger protein 20, transcript variant X9
PHD finger protein 20, transcript variant X1
PHD finger protein 20, transcript variant X6
PHD finger protein 20, transcript variant X8
PHD finger protein 20, transcript variant X4
PHD finger protein 20, transcript variant X3
Src like adaptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Src like adaptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NDRG family member 3, transcript variant X4
NDRG family member 3, transcript variant X3
NDRG family member 3, transcript variant X1
NDRG family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X1
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X2
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X3
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X4
ral GTPase-activating protein subunit beta isoform X1
ral GTPase-activating protein subunit beta isoform X2
ral GTPase-activating protein subunit beta isoform X3
ral GTPase-activating protein subunit beta isoform X4
chromodomain helicase DNA binding protein 6, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X6
chromodomain helicase DNA binding protein 6, transcript variant X1
chromodomain helicase DNA binding protein 6, transcript variant X8
chromodomain helicase DNA binding protein 6, transcript variant X2
chromodomain helicase DNA binding protein 6, transcript variant X3
chromodomain helicase DNA binding protein 6, transcript variant X5
chromodomain helicase DNA binding protein 6, transcript variant X7
chromodomain helicase DNA binding protein 6, transcript variant X9
chromodomain helicase DNA binding protein 6, transcript variant X10
chromodomain helicase DNA binding protein 6, transcript variant X4
chromodomain helicase DNA binding protein 6, transcript variant X13
chromodomain-helicase-DNA-binding protein 6 isoform X1
chromodomain-helicase-DNA-binding protein 6 isoform X7
chromodomain-helicase-DNA-binding protein 6 isoform X6
chromodomain-helicase-DNA-binding protein 6 isoform X8
chromodomain-helicase-DNA-binding protein 6 isoform X9
chromodomain-helicase-DNA-binding protein 6 isoform X2
chromodomain-helicase-DNA-binding protein 6 isoform X3
chromodomain-helicase-DNA-binding protein 6 isoform X4
chromodomain-helicase-DNA-binding protein 6 isoform X12
chromodomain-helicase-DNA-binding protein 6 isoform X10
chromodomain-helicase-DNA-binding protein 6 isoform X11
chromodomain-helicase-DNA-binding protein 6 isoform X5
RB transcriptional corepressor like 1, transcript variant X1
RB transcriptional corepressor like 1, transcript variant X2
RB transcriptional corepressor like 1, transcript variant X3
RB transcriptional corepressor like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
retinoblastoma-like protein 1 isoform X1
retinoblastoma-like protein 1 isoform X2
retinoblastoma-like protein 1 isoform X3
retinoblastoma-like protein 1 isoform X4
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X1
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X4
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X2
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1, transcript variant X3
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X2
phosphatidylinositol glycan anchor biosynthesis class U, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class U protein isoform X2
phosphatidylinositol glycan anchor biosynthesis class U, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class U, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class U protein isoform X1
phosphatidylinositol glycan anchor biosynthesis class U protein isoform X3
tumor protein p53 inducible nuclear protein 2, transcript variant X1
tumor protein p53 inducible nuclear protein 2, transcript variant X2
tumor protein p53 inducible nuclear protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 2 isoform X1
tumor protein p53-inducible nuclear protein 2 isoform X2
tumor protein p53-inducible nuclear protein 2 isoform X3
gamma-glutamyltransferase 7, transcript variant X1
gamma-glutamyltransferase 7, transcript variant X2
uncharacterized LOC125334608, transcript variant X2
uncharacterized LOC125334608, transcript variant X1
TGFB induced factor homeobox 2, transcript variant X2
TGFB induced factor homeobox 2, transcript variant X1
DLG associated protein 4, transcript variant X4
DLG associated protein 4, transcript variant X2
DLG associated protein 4, transcript variant X1
DLG associated protein 4, transcript variant X3
DLG associated protein 4, transcript variant X6
DLG associated protein 4, transcript variant X5
DLG associated protein 4, transcript variant X7
disks large-associated protein 4 isoform X4
disks large-associated protein 4 isoform X2
disks large-associated protein 4 isoform X1
disks large-associated protein 4 isoform X3
disks large-associated protein 4 isoform X6
disks large-associated protein 4 isoform X5
disks large-associated protein 4 isoform X7
erythrocyte membrane protein band 4.1 like 1, transcript variant X10
erythrocyte membrane protein band 4.1 like 1, transcript variant X4
erythrocyte membrane protein band 4.1 like 1, transcript variant X12
erythrocyte membrane protein band 4.1 like 1, transcript variant X9
erythrocyte membrane protein band 4.1 like 1, transcript variant X5
erythrocyte membrane protein band 4.1 like 1, transcript variant X11
erythrocyte membrane protein band 4.1 like 1, transcript variant X8
erythrocyte membrane protein band 4.1 like 1, transcript variant X7
erythrocyte membrane protein band 4.1 like 1, transcript variant X6
erythrocyte membrane protein band 4.1 like 1, transcript variant X1
erythrocyte membrane protein band 4.1 like 1, transcript variant X3
erythrocyte membrane protein band 4.1 like 1, transcript variant X2
serine and arginine rich splicing factor 6
L3MBTL histone methyl-lysine binding protein 1, transcript variant X1
L3MBTL histone methyl-lysine binding protein 1, transcript variant X2
lethal(3)malignant brain tumor-like protein 1 isoform X1
lethal(3)malignant brain tumor-like protein 1 isoform X2
immunoglobulin superfamily member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
centrosome-associated protein CEP250-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC125334894, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC125334894, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC125334894, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125334894, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125334894, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
matrix metallopeptidase 24, transcript variant X1
matrix metallopeptidase 24, transcript variant X2
eukaryotic translation initiation factor 6
family with sequence similarity 83 member C
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X2
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X1
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X1
centrosomal protein 250, transcript variant X1
centrosomal protein 250, transcript variant X2
centrosome-associated protein CEP250 isoform X1
centrosome-associated protein CEP250 isoform X2
centrosomal protein 250, transcript variant X3
centrosome-associated protein CEP250 isoform X3
uncharacterized LOC125335018, transcript variant X2
uncharacterized LOC125335018, transcript variant X1
microtubule associated protein 1 light chain 3 alpha
microtubule-associated proteins 1A/1B light chain 3A
itchy E3 ubiquitin protein ligase, transcript variant X4
itchy E3 ubiquitin protein ligase, transcript variant X3
itchy E3 ubiquitin protein ligase, transcript variant X1
itchy E3 ubiquitin protein ligase, transcript variant X2
E3 ubiquitin-protein ligase Itchy homolog isoform X2
E3 ubiquitin-protein ligase Itchy homolog isoform X1
agouti signaling protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
agouti signaling protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
golgin subfamily A member 6-like protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eukaryotic translation initiation factor 2 subunit beta
eukaryotic translation initiation factor 2 subunit 2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
N-terminal EF-hand calcium binding protein 3, transcript variant X1
N-terminal EF-hand calcium binding protein 3, transcript variant X2
N-terminal EF-hand calcium-binding protein 3
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X4
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X2
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X3
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X1
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X6
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X5
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X7
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X8
TOX high mobility group box family member 2, transcript variant X1
TOX high mobility group box family member 2, transcript variant X2
TOX high mobility group box family member 2, transcript variant X3
TOX high mobility group box family member 2 isoform X1
TOX high mobility group box family member 2 isoform X2
TOX high mobility group box family member 2 isoform X3
ER degradation enhancing alpha-mannosidase like protein 2
ER degradation-enhancing alpha-mannosidase-like protein 2
transient receptor potential cation channel subfamily C member 4 associated protein
short transient receptor potential channel 4-associated protein
myosin heavy chain 7B, transcript variant X1
myosin heavy chain 7B, transcript variant X2
glutathione synthetase, transcript variant X4
glutathione synthetase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutathione synthetase, transcript variant X5
glutathione synthetase, transcript variant X1
glutathione synthetase, transcript variant X2
glutathione synthetase, transcript variant X3
acyl-CoA synthetase short chain family member 2, transcript variant X2
acyl-CoA synthetase short chain family member 2, transcript variant X1
acetyl-coenzyme A synthetase, cytoplasmic isoform X2
acetyl-coenzyme A synthetase, cytoplasmic isoform X1
suppressor of glucose, autophagy associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
uncharacterized LOC125334738, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125334738, transcript variant X1
protein tyrosine phosphatase receptor type T, transcript variant X4
protein tyrosine phosphatase receptor type T, transcript variant X8
protein tyrosine phosphatase receptor type T, transcript variant X10
protein tyrosine phosphatase receptor type T, transcript variant X5
protein tyrosine phosphatase receptor type T, transcript variant X3
protein tyrosine phosphatase receptor type T, transcript variant X6
protein tyrosine phosphatase receptor type T, transcript variant X2
protein tyrosine phosphatase receptor type T, transcript variant X7
protein tyrosine phosphatase receptor type T, transcript variant X9
protein tyrosine phosphatase receptor type T, transcript variant X11
protein tyrosine phosphatase receptor type T, transcript variant X1
receptor-type tyrosine-protein phosphatase T isoform X1
receptor-type tyrosine-protein phosphatase T isoform X4
receptor-type tyrosine-protein phosphatase T isoform X8
receptor-type tyrosine-protein phosphatase T isoform X10
receptor-type tyrosine-protein phosphatase T isoform X5
receptor-type tyrosine-protein phosphatase T isoform X3
receptor-type tyrosine-protein phosphatase T isoform X6
receptor-type tyrosine-protein phosphatase T isoform X2
receptor-type tyrosine-protein phosphatase T isoform X7
receptor-type tyrosine-protein phosphatase T isoform X9
receptor-type tyrosine-protein phosphatase T isoform X11
MYB proto-oncogene like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MYB proto-oncogene like 2, transcript variant X3
MYB proto-oncogene like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
intraflagellar transport protein 52 homolog
serum/glucocorticoid regulated kinase 2, transcript variant X2
serum/glucocorticoid regulated kinase 2, transcript variant X3
serum/glucocorticoid regulated kinase 2, transcript variant X4
serum/glucocorticoid regulated kinase 2, transcript variant X1
serine/threonine-protein kinase Sgk2 isoform X2
serine/threonine-protein kinase Sgk2 isoform X3
serine/threonine-protein kinase Sgk2 isoform X4
serine/threonine-protein kinase Sgk2 isoform X1
vesicular inhibitory amino acid transporter
uncharacterized LOC125334775, transcript variant X1
uncharacterized LOC125334775, transcript variant X2
uncharacterized LOC125334776, transcript variant X2
uncharacterized LOC125334776, transcript variant X1
Rho GTPase activating protein 40, transcript variant X3
Rho GTPase activating protein 40, transcript variant X4
Rho GTPase activating protein 40, transcript variant X2
Rho GTPase activating protein 40, transcript variant X1
rho GTPase-activating protein 40 isoform X4
rho GTPase-activating protein 40 isoform X2
rho GTPase-activating protein 40 isoform X1
rho GTPase-activating protein 40 isoform X3
protein phosphatase 1 regulatory subunit 16B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 16B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 16B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 16B
DEAH-box helicase 35, transcript variant X1
DEAH-box helicase 35, transcript variant X2
probable ATP-dependent RNA helicase DHX35 isoform X1
probable ATP-dependent RNA helicase DHX35 isoform X2
uncharacterized LOC125334806, transcript variant X1
uncharacterized LOC125334806, transcript variant X2
uncharacterized LOC125334804, transcript variant X3
uncharacterized LOC125334804, transcript variant X2
uncharacterized LOC125334804, transcript variant X4
uncharacterized LOC125334804, transcript variant X1
uncharacterized LOC125334804, transcript variant X6
uncharacterized LOC125334804, transcript variant X9
uncharacterized LOC125334804, transcript variant X7
uncharacterized LOC125334804, transcript variant X5
uncharacterized LOC125334804, transcript variant X8
uncharacterized LOC125334804, transcript variant X10
phospholipase C gamma 1, transcript variant X1
phospholipase C gamma 1, transcript variant X3
phospholipase C gamma 1, transcript variant X2
phospholipase C gamma 1, transcript variant X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X4
zinc fingers and homeoboxes 3, transcript variant X2
zinc fingers and homeoboxes 3, transcript variant X4
zinc fingers and homeoboxes 3, transcript variant X1
zinc fingers and homeoboxes 3, transcript variant X5
zinc fingers and homeoboxes 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X1
mannosidase beta like, transcript variant X1
mannosidase beta like, transcript variant X2
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X1
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X2
proto-oncogene tyrosine-protein kinase Src isoform X1
proto-oncogene tyrosine-protein kinase Src isoform X2
BLCAP apoptosis inducing factor, transcript variant X3
BLCAP apoptosis inducing factor, transcript variant X1
BLCAP apoptosis inducing factor, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class T, transcript variant X2
phosphatidylinositol glycan anchor biosynthesis class T, transcript variant X1
GPI transamidase component PIG-T isoform X2
GPI transamidase component PIG-T isoform X1
dysbindin domain containing 2, transcript variant X2
dysbindin domain containing 2, transcript variant X1
dysbindin domain containing 2, transcript variant X4
dysbindin domain containing 2, transcript variant X3
dysbindin domain-containing protein 2 isoform X2
dysbindin domain-containing protein 2 isoform X1
dysbindin domain-containing protein 2 isoform X3
recombination signal binding protein for immunoglobulin kappa J region like
recombining binding protein suppressor of hairless-like protein
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X1
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X3
potassium voltage-gated channel modifier subfamily S member 1, transcript variant X2
potassium voltage-gated channel subfamily S member 1
serine/threonine kinase 4, transcript variant X2
serine/threonine kinase 4, transcript variant X1
serine/threonine-protein kinase 4 isoform X2
serine/threonine-protein kinase 4 isoform X1
translocase of outer mitochondrial membrane 34
mitochondrial import receptor subunit TOM34
poly(A) binding protein cytoplasmic 1 like, transcript variant X1
poly(A) binding protein cytoplasmic 1 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta, transcript variant X1
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta, transcript variant X2
regulating synaptic membrane exocytosis 4
regulating synaptic membrane exocytosis protein 4
potassium two pore domain channel subfamily K member 15
cellular communication network factor 5, transcript variant X3
cellular communication network factor 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cellular communication network factor 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
adenosine deaminase, transcript variant X1
adenosine deaminase, transcript variant X2
cAMP-dependent protein kinase inhibitor gamma, transcript variant X2
cAMP-dependent protein kinase inhibitor gamma, transcript variant X1
cAMP-dependent protein kinase inhibitor gamma
alpha tocopherol transfer protein like, transcript variant X2
alpha tocopherol transfer protein like, transcript variant X1
hepatocyte nuclear factor 4 alpha, transcript variant X3
hepatocyte nuclear factor 4 alpha, transcript variant X2
hepatocyte nuclear factor 4 alpha, transcript variant X4
hepatocyte nuclear factor 4 alpha, transcript variant X1
hepatocyte nuclear factor 4-alpha isoform X3
hepatocyte nuclear factor 4-alpha isoform X2
hepatocyte nuclear factor 4-alpha isoform X4
hepatocyte nuclear factor 4-alpha isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fat storage inducing transmembrane protein 2
ganglioside induced differentiation associated protein 1 like 1
ganglioside-induced differentiation-associated protein 1-like 1
oxidative stress-responsive serine-rich protein 1-like, transcript variant X1
oxidative stress-responsive serine-rich protein 1-like, transcript variant X2
oxidative stress-responsive serine-rich protein 1-like
oxidative stress-responsive serine-rich protein 1-like, transcript variant X6
oxidative stress-responsive serine-rich protein 1-like, transcript variant X3
oxidative stress-responsive serine-rich protein 1-like, transcript variant X4
oxidative stress-responsive serine-rich protein 1-like, transcript variant X5
thyrotropin-releasing hormone receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125334934, transcript variant X2
uncharacterized LOC125334934, transcript variant X3
uncharacterized LOC125334934, transcript variant X1
osteoclast stimulatory transmembrane protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
osteoclast stimulatory transmembrane protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
osteoclast stimulatory transmembrane protein
solute carrier family 13 member 3, transcript variant X1
solute carrier family 13 member 3, transcript variant X2
solute carrier family 13 member 3 isoform X1
solute carrier family 13 member 3 isoform X2
solute carrier family 2 member 10, transcript variant X1
solute carrier family 2 member 10, transcript variant X2
solute carrier family 2, facilitated glucose transporter member 10 isoform X1
solute carrier family 2, facilitated glucose transporter member 10 isoform X2
EYA transcriptional coactivator and phosphatase 2, transcript variant X4
EYA transcriptional coactivator and phosphatase 2, transcript variant X5
EYA transcriptional coactivator and phosphatase 2, transcript variant X1
EYA transcriptional coactivator and phosphatase 2, transcript variant X6
EYA transcriptional coactivator and phosphatase 2, transcript variant X2
EYA transcriptional coactivator and phosphatase 2, transcript variant X3
zinc finger MYND-type containing 8, transcript variant X5
zinc finger MYND-type containing 8, transcript variant X1
zinc finger MYND-type containing 8, transcript variant X7
zinc finger MYND-type containing 8, transcript variant X6
zinc finger MYND-type containing 8, transcript variant X2
zinc finger MYND-type containing 8, transcript variant X3
zinc finger MYND-type containing 8, transcript variant X4
protein kinase C-binding protein 1 isoform X3
protein kinase C-binding protein 1 isoform X1
protein kinase C-binding protein 1 isoform X5
protein kinase C-binding protein 1 isoform X2
protein kinase C-binding protein 1 isoform X4
protein-glutamine gamma-glutamyltransferase E-like, transcript variant X2
protein-glutamine gamma-glutamyltransferase E-like isoform X2
protein-glutamine gamma-glutamyltransferase E-like, transcript variant X1
protein-glutamine gamma-glutamyltransferase E-like isoform X1
protein-glutamine gamma-glutamyltransferase 6-like, transcript variant X2
protein-glutamine gamma-glutamyltransferase 6-like, transcript variant X1
protein-glutamine gamma-glutamyltransferase 6-like
cyclin D1 binding protein 1, transcript variant X1
cyclin D1 binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
NFX1-type zinc finger-containing protein 1
DEAD-box helicase 27, transcript variant X1
DEAD-box helicase 27, transcript variant X2
probable ATP-dependent RNA helicase DDX27
small nuclear ribonucleoprotein polypeptides B and B1
small nuclear ribonucleoprotein-associated proteins B and B'
engulfment and cell motility 2, transcript variant X6
engulfment and cell motility 2, transcript variant X1
engulfment and cell motility 2, transcript variant X5
engulfment and cell motility 2, transcript variant X2
engulfment and cell motility 2, transcript variant X3
engulfment and cell motility 2, transcript variant X7
engulfment and cell motility 2, transcript variant X4
engulfment and cell motility protein 2 isoform X1
engulfment and cell motility protein 2 isoform X3
engulfment and cell motility protein 2 isoform X2
engulfment and cell motility protein 2 isoform X4
engulfment and cell motility 2, transcript variant X8
engulfment and cell motility protein 2 isoform X5
solute carrier family 35 member C2, transcript variant X1
solute carrier family 35 member C2, transcript variant X3
solute carrier family 35 member C2, transcript variant X2
solute carrier family 35 member C2 isoform X1
solute carrier family 35 member C2 isoform X3
solute carrier family 35 member C2 isoform X2
solute carrier family 35 member C2, transcript variant X4
solute carrier family 35 member C2 isoform X4
tumor necrosis factor receptor superfamily member 5 isoform X4
tumor necrosis factor receptor superfamily member 5 isoform X2
tumor necrosis factor receptor superfamily member 5 isoform X3
tumor necrosis factor receptor superfamily member 5 isoform X1
nuclear receptor coactivator 5, transcript variant X1
nuclear receptor coactivator 5, transcript variant X3
nuclear receptor coactivator 5, transcript variant X2
nuclear receptor coactivator 5 isoform X1
nuclear receptor coactivator 5 isoform X2
nuclear receptor coactivator 5 isoform X3
solute carrier family 12 member 5, transcript variant X3
solute carrier family 12 member 5, transcript variant X2
solute carrier family 12 member 5, transcript variant X1
solute carrier family 12 member 5 isoform X2
solute carrier family 12 member 5 isoform X1
zinc finger protein 335, transcript variant X2
zinc finger protein 335, transcript variant X1
zinc finger protein 335, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger protein 335, transcript variant X4
zinc finger protein 335, transcript variant X3
zinc finger protein 335, transcript variant X7
zinc finger protein 335, transcript variant X8
zinc finger protein 335, transcript variant X5
zinc finger protein 335, transcript variant X6
iroquois-class homeodomain protein IRX-2-like
phosphorylated CTD interacting factor 1, transcript variant X2
phosphorylated CTD interacting factor 1, transcript variant X1
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: phospholipid transfer protein
neuralized E3 ubiquitin protein ligase 2, transcript variant X2
neuralized E3 ubiquitin protein ligase 2, transcript variant X1
zinc finger SWIM domain-containing protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger SWIM domain-containing protein 1-like
sorting nexin family member 21, transcript variant X2
sorting nexin family member 21, transcript variant X4
sorting nexin family member 21, transcript variant X1
sorting nexin family member 21, transcript variant X3
regulator of G-protein signaling 9-binding protein-like
deoxynucleotidyltransferase terminal interacting protein 1, transcript variant X2
deoxynucleotidyltransferase terminal interacting protein 1, transcript variant X1
deoxynucleotidyltransferase terminal-interacting protein 1 isoform X2
deoxynucleotidyltransferase terminal-interacting protein 1 isoform X1
serine peptidase inhibitor, Kunitz type 4, transcript variant X1
serine peptidase inhibitor, Kunitz type 4, transcript variant X2
kunitz-type protease inhibitor 4 isoform X1
kunitz-type protease inhibitor 4 isoform X2
WAP four-disulfide core domain protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
WAP four-disulfide core domain protein 3-like, transcript variant X1
WAP four-disulfide core domain protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
WAP four-disulfide core domain protein 3-like isoform X1
WAP four-disulfide core domain protein 3-like isoform X2
WAP four-disulfide core domain protein 2-like
V-set and transmembrane domain containing 2 like, transcript variant X1
V-set and transmembrane domain containing 2 like, transcript variant X2
V-set and transmembrane domain-containing protein 2-like protein isoform X1
V-set and transmembrane domain-containing protein 2-like protein isoform X2
V-set and transmembrane domain containing 2 like, transcript variant X3
V-set and transmembrane domain-containing protein 2-like protein isoform X3
TELO2 interacting protein 1, transcript variant X1
TELO2 interacting protein 1, transcript variant X2
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X1
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X1
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X2
protein-glutamine gamma-glutamyltransferase 2
KIAA1755 ortholog, transcript variant X2
KIAA1755 ortholog, transcript variant X1
uncharacterized protein KIAA1755 homolog isoform X2
uncharacterized protein KIAA1755 homolog isoform X1
bactericidal permeability-increasing protein-like
CDK5 regulatory subunit associated protein 1, transcript variant X1
CDK5 regulatory subunit associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mitochondrial tRNA methylthiotransferase CDK5RAP1 isoform X1
mitochondrial tRNA methylthiotransferase CDK5RAP1 isoform X2
BPI fold-containing family B member 4-like, transcript variant X3
BPI fold-containing family B member 4-like, transcript variant X1
BPI fold-containing family B member 4-like, transcript variant X2
BPI fold-containing family B member 4-like, transcript variant X4
BPI fold-containing family B member 4-like isoform X4
BPI fold-containing family B member 4-like isoform X2
BPI fold-containing family B member 4-like isoform X3
BPI fold-containing family B member 4-like isoform X1
BPI fold-containing family B member 3-like, transcript variant X1
BPI fold-containing family B member 3-like, transcript variant X2
BPI fold-containing family B member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
BPI fold-containing family B member 4-like
microtubule associated protein RP/EB family member 1, transcript variant X2
microtubule associated protein RP/EB family member 1, transcript variant X1
microtubule-associated protein RP/EB family member 1 isoform X2
microtubule-associated protein RP/EB family member 1 isoform X1
DNA methyltransferase 3 beta, transcript variant X2
DNA methyltransferase 3 beta, transcript variant X1
DNA (cytosine-5)-methyltransferase 3B isoform X2
DNA (cytosine-5)-methyltransferase 3B isoform X1
COMM domain containing 7, transcript variant X1
COMM domain containing 7, transcript variant X2
COMM domain-containing protein 7 isoform X1
COMM domain-containing protein 7 isoform X2
nucleolar protein 4 like, transcript variant X1
nucleolar protein 4 like, transcript variant X3
nucleolar protein 4 like, transcript variant X2
nucleolar protein 4 like, transcript variant X4
GDP-fucose protein O-fucosyltransferase 1
HCK proto-oncogene, Src family tyrosine kinase
cerebral cavernous malformations 2 protein-like
p53 and DNA damage regulated 1, transcript variant X2
p53 and DNA damage regulated 1, transcript variant X1
p53 and DNA damage-regulated protein 1 isoform X1
p53 and DNA damage-regulated protein 1 isoform X2
myosin light chain kinase 2, transcript variant X2
myosin light chain kinase 2, transcript variant X1
myosin light chain kinase 2, skeletal/cardiac muscle isoform X1
myosin light chain kinase 2, skeletal/cardiac muscle isoform X2
TPX2 microtubule nucleation factor, transcript variant X2
TPX2 microtubule nucleation factor, transcript variant X1
histocompatibility minor 13, transcript variant X2
histocompatibility minor 13, transcript variant X1
minor histocompatibility antigen H13 isoform X2
minor histocompatibility antigen H13 isoform X1
TBC1 domain family member 20, transcript variant X4
TBC1 domain family member 20, transcript variant X3
TBC1 domain family member 20, transcript variant X5
TBC1 domain family member 20, transcript variant X2
TBC1 domain family member 20, transcript variant X1
casein kinase 2 alpha 1, transcript variant X2
casein kinase 2 alpha 1, transcript variant X1
casein kinase II subunit alpha isoform X2
casein kinase II subunit alpha isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
scratch family transcriptional repressor 2
solute carrier family 52 member 3, transcript variant X4
solute carrier family 52 member 3, transcript variant X1
solute carrier family 52 member 3, transcript variant X3
solute carrier family 52 member 3, transcript variant X2
solute carrier family 52 member 3, transcript variant X5
solute carrier family 52, riboflavin transporter, member 3
family with sequence similarity 110 member A
WAS/WASL-interacting protein family member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
double-strand-break repair protein rad21-like protein 1
peptidyl-prolyl cis-trans isomerase FKBP1A
signal-regulatory protein beta-1-like, transcript variant X2
signal-regulatory protein beta-1-like, transcript variant X1
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X2
signal-regulatory protein beta-1-like isoform X1
signal-regulatory protein beta-1-like, transcript variant X3
signal-regulatory protein beta-1-like, transcript variant X4
uncharacterized protein LOC125334836 isoform X2
uncharacterized protein LOC125334836 isoform X3
uncharacterized protein LOC125334836 isoform X4
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X1
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X2
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X3
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X1
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X3
fibronectin type III domain containing 11
fibronectin type III domain-containing protein 11
helicase with zinc finger 2, transcript variant X3
helicase with zinc finger 2, transcript variant X2
helicase with zinc finger 2, transcript variant X1
glucocorticoid modulatory element binding protein 2, transcript variant X2
glucocorticoid modulatory element binding protein 2, transcript variant X1
glucocorticoid modulatory element-binding protein 2 isoform X1
glucocorticoid modulatory element-binding protein 2 isoform X2
regulator of telomere elongation helicase 1, transcript variant X1
regulator of telomere elongation helicase 1, transcript variant X4
regulator of telomere elongation helicase 1, transcript variant X2
regulator of telomere elongation helicase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
regulator of telomere elongation helicase 1 isoform X1
regulator of telomere elongation helicase 1 isoform X2
regulator of telomere elongation helicase 1 isoform X4
regulator of telomere elongation helicase 1 isoform X3
TNF receptor superfamily member 6b, transcript variant X3
TNF receptor superfamily member 6b, transcript variant X4
TNF receptor superfamily member 6b, transcript variant X5
TNF receptor superfamily member 6b, transcript variant X1
TNF receptor superfamily member 6b, transcript variant X2
tumor necrosis factor receptor superfamily member 6B isoform X1
tumor necrosis factor receptor superfamily member 6B isoform X2
ADP ribosylation factor related protein 1
ADP-ribosylation factor-related protein 1
zinc finger CCCH-type and G-patch domain containing
zinc finger CCCH-type with G patch domain-containing protein
zinc finger and BTB domain containing 46, transcript variant X5
zinc finger and BTB domain containing 46, transcript variant X6
zinc finger and BTB domain containing 46, transcript variant X1
zinc finger and BTB domain containing 46, transcript variant X4
zinc finger and BTB domain containing 46, transcript variant X7
zinc finger and BTB domain containing 46, transcript variant X2
zinc finger and BTB domain containing 46, transcript variant X3
zinc finger and BTB domain-containing protein 46 isoform X3
zinc finger and BTB domain-containing protein 46 isoform X1
zinc finger and BTB domain-containing protein 46 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X2
uridine-cytidine kinase 1 like 1, transcript variant X3
uridine-cytidine kinase 1 like 1, transcript variant X1
uridine-cytidine kinase 1 like 1, transcript variant X2
uridine-cytidine kinase-like 1 isoform X3
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase-like 1 isoform X2
zinc finger protein 512B, transcript variant X2
zinc finger protein 512B, transcript variant X3
zinc finger protein 512B, transcript variant X1
zinc finger protein 512B, transcript variant X4
zinc finger protein 512B, transcript variant X5
sterile alpha motif domain containing 10, transcript variant X4
sterile alpha motif domain containing 10, transcript variant X1
sterile alpha motif domain containing 10, transcript variant X3
sterile alpha motif domain containing 10, transcript variant X2
sterile alpha motif domain containing 10, transcript variant X5
sterile alpha motif domain-containing protein 10 isoform X4
sterile alpha motif domain-containing protein 10 isoform X1
sterile alpha motif domain-containing protein 10 isoform X2
sterile alpha motif domain-containing protein 10 isoform X3
sterile alpha motif domain-containing protein 10 isoform X5
uncharacterized protein C20orf204 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
transcription elongation factor A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
transcription elongation factor A2, transcript variant X2
transcription elongation factor A protein 2 isoform X2
transcription elongation factor A protein 2 isoform X1
transcription elongation factor A2, transcript variant X3
transcription elongation factor A protein 2 isoform X3
transcription elongation factor A2, transcript variant X4
transcription elongation factor A protein 2 isoform X4
regulator of G protein signaling 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
regulator of G protein signaling 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC125334732, transcript variant X1
uncharacterized LOC125334732, transcript variant X2
uncharacterized LOC125334842, transcript variant X1
uncharacterized LOC125334842, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125334998, transcript variant X3
uncharacterized LOC125334998, transcript variant X4
uncharacterized LOC125334998, transcript variant X2
uncharacterized LOC125334998, transcript variant X1
uncharacterized LOC125334998, transcript variant X5
uncharacterized LOC125334998, transcript variant X8
uncharacterized LOC125334998, transcript variant X7
uncharacterized LOC125334998, transcript variant X6
uncharacterized protein LOC125334998 isoform X1
uncharacterized protein LOC125334998 isoform X2
uncharacterized protein LOC125334998 isoform X4
uncharacterized protein LOC125334998 isoform X3
myelin transcription factor 1, transcript variant X1
myelin transcription factor 1, transcript variant X2
myelin transcription factor 1, transcript variant X3
myelin transcription factor 1 isoform X1
myelin transcription factor 1 isoform X2
myelin transcription factor 1 isoform X3
myelin transcription factor 1, transcript variant X5
myelin transcription factor 1, transcript variant X4
myelin transcription factor 1, transcript variant X6
myelin transcription factor 1 isoform X4
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
protein-L-isoaspartate O-methyltransferase domain-containing protein 2
peroxidasin homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
peroxidasin homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
pancreatic progenitor cell differentiation and proliferation factor, transcript variant X2
pancreatic progenitor cell differentiation and proliferation factor, transcript variant X1
pancreatic progenitor cell differentiation and proliferation factor
eukaryotic translation elongation factor 1 alpha 2
potassium voltage-gated channel subfamily Q member 2, transcript variant X1
potassium voltage-gated channel subfamily Q member 2, transcript variant X12
potassium voltage-gated channel subfamily Q member 2, transcript variant X2
potassium voltage-gated channel subfamily Q member 2, transcript variant X5
potassium voltage-gated channel subfamily Q member 2, transcript variant X6
potassium voltage-gated channel subfamily Q member 2, transcript variant X15
potassium voltage-gated channel subfamily Q member 2, transcript variant X11
potassium voltage-gated channel subfamily Q member 2, transcript variant X17
potassium voltage-gated channel subfamily Q member 2, transcript variant X4
potassium voltage-gated channel subfamily Q member 2, transcript variant X8
potassium voltage-gated channel subfamily Q member 2, transcript variant X10
potassium voltage-gated channel subfamily Q member 2, transcript variant X3
potassium voltage-gated channel subfamily Q member 2, transcript variant X9
potassium voltage-gated channel subfamily Q member 2, transcript variant X16
potassium voltage-gated channel subfamily Q member 2, transcript variant X14
potassium voltage-gated channel subfamily Q member 2, transcript variant X7
potassium voltage-gated channel subfamily Q member 2, transcript variant X13
potassium voltage-gated channel subfamily Q member 2, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2 isoform X1
potassium voltage-gated channel subfamily KQT member 2 isoform X12
potassium voltage-gated channel subfamily KQT member 2 isoform X2
potassium voltage-gated channel subfamily KQT member 2 isoform X5
potassium voltage-gated channel subfamily KQT member 2 isoform X6
potassium voltage-gated channel subfamily KQT member 2 isoform X15
potassium voltage-gated channel subfamily KQT member 2 isoform X11
potassium voltage-gated channel subfamily KQT member 2 isoform X17
potassium voltage-gated channel subfamily KQT member 2 isoform X4
potassium voltage-gated channel subfamily KQT member 2 isoform X8
potassium voltage-gated channel subfamily KQT member 2 isoform X10
potassium voltage-gated channel subfamily KQT member 2 isoform X3
potassium voltage-gated channel subfamily KQT member 2 isoform X9
potassium voltage-gated channel subfamily KQT member 2 isoform X16
potassium voltage-gated channel subfamily KQT member 2 isoform X14
potassium voltage-gated channel subfamily KQT member 2 isoform X7
potassium voltage-gated channel subfamily KQT member 2 isoform X13
potassium voltage-gated channel subfamily KQT member 2 isoform X18
cholinergic receptor nicotinic alpha 4 subunit
neuronal acetylcholine receptor subunit alpha-4
collagen type XX alpha 1 chain, transcript variant X2
collagen type XX alpha 1 chain, transcript variant X1
DEP domain-containing mTOR-interacting protein-like, transcript variant X1
DEP domain-containing mTOR-interacting protein-like, transcript variant X2
DEP domain-containing mTOR-interacting protein-like isoform X2
DEP domain-containing mTOR-interacting protein-like isoform X1
ADP ribosylation factor GTPase activating protein 1, transcript variant X7
ADP ribosylation factor GTPase activating protein 1, transcript variant X4
ADP ribosylation factor GTPase activating protein 1, transcript variant X5
ADP ribosylation factor GTPase activating protein 1, transcript variant X2
ADP ribosylation factor GTPase activating protein 1, transcript variant X6
ADP ribosylation factor GTPase activating protein 1, transcript variant X3
ADP ribosylation factor GTPase activating protein 1, transcript variant X1
ADP ribosylation factor GTPase activating protein 1, transcript variant X8
ADP-ribosylation factor GTPase-activating protein 1 isoform X8
ADP-ribosylation factor GTPase-activating protein 1 isoform X7
ADP-ribosylation factor GTPase-activating protein 1 isoform X4
ADP-ribosylation factor GTPase-activating protein 1 isoform X5
ADP-ribosylation factor GTPase-activating protein 1 isoform X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X6
ADP-ribosylation factor GTPase-activating protein 1 isoform X3
ADP-ribosylation factor GTPase-activating protein 1 isoform X1
sodium/potassium transporting ATPase interacting 4, transcript variant X3
sodium/potassium transporting ATPase interacting 4, transcript variant X2
sodium/potassium transporting ATPase interacting 4, transcript variant X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X2
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X1
baculoviral IAP repeat containing 7, transcript variant X2
baculoviral IAP repeat containing 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
baculoviral IAP repeat-containing protein 7 isoform X2
baculoviral IAP repeat-containing protein 7 isoform X1
baculoviral IAP repeat containing 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
baculoviral IAP repeat-containing protein 7 isoform X3
YTH N6-methyladenosine RNA binding protein 1, transcript variant X1
YTH N6-methyladenosine RNA binding protein 1, transcript variant X2
YTH domain-containing family protein 1 isoform X2
YTH domain-containing family protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125334847, transcript variant X1
uncharacterized LOC125334847, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC125334658, transcript variant X3
uncharacterized LOC125334658, transcript variant X4
uncharacterized LOC125334658, transcript variant X1
uncharacterized LOC125334658, transcript variant X2
basic helix-loop-helix family member e23
class E basic helix-loop-helix protein 23
solute carrier family 17 member 9, transcript variant X1
solute carrier family 17 member 9, transcript variant X3
solute carrier family 17 member 9, transcript variant X5
solute carrier family 17 member 9 isoform X3
solute carrier family 17 member 9 isoform X1
solute carrier family 17 member 9 isoform X5
solute carrier family 17 member 9, transcript variant X4
solute carrier family 17 member 9, transcript variant X2
solute carrier family 17 member 9 isoform X4
solute carrier family 17 member 9 isoform X2
glucose-induced degradation protein 8 homolog
uncharacterized LOC125334544, transcript variant X1
uncharacterized LOC125334544, transcript variant X2
death inducer-obliterator 1, transcript variant X2
death inducer-obliterator 1, transcript variant X1
death inducer-obliterator 1, transcript variant X3
transcription factor like 5, transcript variant X2
transcription factor like 5, transcript variant X1
opioid growth factor receptor, transcript variant X1
opioid growth factor receptor, transcript variant X3
opioid growth factor receptor, transcript variant X2
opioid growth factor receptor isoform X3
opioid growth factor receptor isoform X2
opioid growth factor receptor isoform X1
solute carrier organic anion transporter family member 4A1, transcript variant X1
solute carrier organic anion transporter family member 4A1, transcript variant X2
solute carrier organic anion transporter family member 4A1 isoform X1
solute carrier organic anion transporter family member 4A1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
solute carrier organic anion transporter family member 4A1 isoform X2
uncharacterized LOC125334803, transcript variant X2
uncharacterized LOC125334803, transcript variant X5
uncharacterized LOC125334803, transcript variant X1
uncharacterized LOC125334803, transcript variant X6
uncharacterized LOC125334803, transcript variant X4
uncharacterized LOC125334803, transcript variant X3
laminin subunit alpha 5, transcript variant X1
laminin subunit alpha 5, transcript variant X2
laminin subunit alpha 5, transcript variant X3
ADRM1 26S proteasome ubiquitin receptor, transcript variant X2
ADRM1 26S proteasome ubiquitin receptor, transcript variant X3
ADRM1 26S proteasome ubiquitin receptor, transcript variant X1
proteasomal ubiquitin receptor ADRM1 isoform X2
proteasomal ubiquitin receptor ADRM1 isoform X1
oxysterol-binding protein-related protein 2
mitochondrial ribosome associated GTPase 2
mitochondrial ribosome-associated GTPase 2
SS18L1 subunit of BAF chromatin remodeling complex
LSM family member 14B, transcript variant X4
LSM family member 14B, transcript variant X3
LSM family member 14B, transcript variant X2
LSM family member 14B, transcript variant X1
uncharacterized LOC125335045, transcript variant X1
uncharacterized LOC125335045, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125335045, transcript variant X3
TATA-box binding protein associated factor 4
transcription initiation factor TFIID subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 217 member B, transcript variant X5
family with sequence similarity 217 member B, transcript variant X1
family with sequence similarity 217 member B, transcript variant X3
family with sequence similarity 217 member B, transcript variant X4
family with sequence similarity 217 member B, transcript variant X2
protein phosphatase 1 regulatory subunit 3D
synaptonemal complex protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
synaptonemal complex protein 2, transcript variant X2
synaptonemal complex protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
synaptonemal complex protein 2, transcript variant X4
synaptonemal complex protein 2 isoform X1
synaptonemal complex protein 2 isoform X2
synaptonemal complex protein 2 isoform X3
phosphatase and actin regulator 3, transcript variant X1
phosphatase and actin regulator 3, transcript variant X2
phosphatase and actin regulator 3 isoform X1
phosphatase and actin regulator 3 isoform X2
uncharacterized LOC125334862, transcript variant X1
uncharacterized LOC125334862, transcript variant X6
uncharacterized LOC125334862, transcript variant X2
uncharacterized LOC125334862, transcript variant X4
uncharacterized LOC125334862, transcript variant X5
uncharacterized LOC125334862, transcript variant X3
zinc finger protein 831, transcript variant X1
zinc finger protein 831, transcript variant X2
zinc finger protein 831, transcript variant X3
zinc finger protein 831, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
LOW QUALITY PROTEIN: PRELI domain containing protein 3B
ATP synthase subunit epsilon, mitochondrial
tubulin beta 1 class VI, transcript variant X2
tubulin beta 1 class VI, transcript variant X1
negative elongation factor complex member C/D, transcript variant X2
negative elongation factor complex member C/D, transcript variant X3
negative elongation factor C/D isoform X2
negative elongation factor C/D isoform X3
negative elongation factor complex member C/D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
negative elongation factor C/D isoform X1
GNAS complex locus, transcript variant X1
GNAS complex locus, transcript variant X2
guanine nucleotide-binding protein G(s) subunit alpha isoform X1
guanine nucleotide-binding protein G(s) subunit alpha isoform X2
uncharacterized LOC125334577, transcript variant X2
uncharacterized LOC125334577, transcript variant X1
vesicle-associated membrane protein-associated protein B/C
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X2
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X2
uncharacterized LOC125334692, transcript variant X2
uncharacterized LOC125334692, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized protein C20orf85 homolog
prostate transmembrane protein, androgen induced 1, transcript variant X1
prostate transmembrane protein, androgen induced 1, transcript variant X2
prostate transmembrane protein, androgen induced 1, transcript variant X3
prostate transmembrane protein, androgen induced 1, transcript variant X4
phosphoenolpyruvate carboxykinase, cytosolic [GTP]
CCCTC-binding factor like, transcript variant X1
CCCTC-binding factor like, transcript variant X5
CCCTC-binding factor like, transcript variant X7
CCCTC-binding factor like, transcript variant X2
CCCTC-binding factor like, transcript variant X4
CCCTC-binding factor like, transcript variant X6
CCCTC-binding factor like, transcript variant X3
transcriptional repressor CTCFL isoform X1
transcriptional repressor CTCFL isoform X2
transcriptional repressor CTCFL isoform X4
transcriptional repressor CTCFL isoform X3
uncharacterized LOC125334888, transcript variant X1
uncharacterized LOC125334888, transcript variant X2
uncharacterized LOC125334702, transcript variant X3
uncharacterized LOC125334702, transcript variant X1
uncharacterized LOC125334702, transcript variant X2
RNA binding motif protein 38, transcript variant X2
RNA binding motif protein 38, transcript variant X1
SPO11 initiator of meiotic double stranded breaks, transcript variant X1
SPO11 initiator of meiotic double stranded breaks, transcript variant X2
meiotic recombination protein SPO11 isoform X1
meiotic recombination protein SPO11 isoform X2
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X2
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X3
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X1
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like
Cas scaffold protein family member 4, transcript variant X3
Cas scaffold protein family member 4, transcript variant X1
Cas scaffold protein family member 4, transcript variant X2
cas scaffolding protein family member 4 isoform X3
cas scaffolding protein family member 4 isoform X1
cas scaffolding protein family member 4 isoform X2
family with sequence similarity 210 member B
formin-like protein 17, transcript variant X1
formin-like protein 17, transcript variant X2
docking protein 5, transcript variant X1
docking protein 5, transcript variant X2
docking protein 5, transcript variant X3
uncharacterized LOC125334770, transcript variant X7
uncharacterized LOC125334770, transcript variant X5
uncharacterized LOC125334770, transcript variant X6
uncharacterized LOC125334770, transcript variant X4
uncharacterized LOC125334770, transcript variant X3
uncharacterized LOC125334770, transcript variant X2
uncharacterized LOC125334770, transcript variant X1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
brain enriched myelin associated protein 1, transcript variant X5
brain enriched myelin associated protein 1, transcript variant X2
brain enriched myelin associated protein 1, transcript variant X6
brain enriched myelin associated protein 1, transcript variant X1
brain enriched myelin associated protein 1, transcript variant X3
breast carcinoma-amplified sequence 1 isoform X1
breast carcinoma-amplified sequence 1 isoform X3
breast carcinoma-amplified sequence 1 isoform X6
breast carcinoma-amplified sequence 1 isoform X2
breast carcinoma-amplified sequence 1 isoform X5
brain enriched myelin associated protein 1, transcript variant X4
breast carcinoma-amplified sequence 1 isoform X4
zinc finger protein 217, transcript variant X1
zinc finger protein 217, transcript variant X2
zinc finger protein 217, transcript variant X3
zinc finger protein 217, transcript variant X4
teashirt zinc finger homeobox 2, transcript variant X3
teashirt zinc finger homeobox 2, transcript variant X1
teashirt zinc finger homeobox 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATPase phospholipid transporting 9A (putative), transcript variant X4
probable phospholipid-transporting ATPase IIA isoform X3
ATPase phospholipid transporting 9A (putative), transcript variant X1
ATPase phospholipid transporting 9A (putative), transcript variant X2
ATPase phospholipid transporting 9A (putative), transcript variant X3
probable phospholipid-transporting ATPase IIA isoform X1
probable phospholipid-transporting ATPase IIA isoform X2
nuclear factor of activated T cells 2, transcript variant X2
nuclear factor of activated T cells 2, transcript variant X1
nuclear factor of activated T cells 2, transcript variant X4
nuclear factor of activated T-cells, cytoplasmic 2 isoform X1
nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
nuclear factor of activated T cells 2, transcript variant X3
nuclear factor of activated T cells 2, transcript variant X5
nuclear factor of activated T-cells, cytoplasmic 2 isoform X3
nuclear factor of activated T-cells, cytoplasmic 2 isoform X4
uncharacterized LOC125334705, transcript variant X5
uncharacterized LOC125334705, transcript variant X4
uncharacterized LOC125334705, transcript variant X3
uncharacterized LOC125334705, transcript variant X2
uncharacterized LOC125334705, transcript variant X1
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X2
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X1
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X3
potassium voltage-gated channel subfamily G member 1
adenylyltransferase and sulfurtransferase MOCS3
dolichyl-phosphate mannosyltransferase subunit 1, catalytic
dolichol-phosphate mannosyltransferase subunit 1
activity dependent neuroprotector homeobox, transcript variant X1
activity dependent neuroprotector homeobox, transcript variant X8
activity dependent neuroprotector homeobox, transcript variant X9
activity dependent neuroprotector homeobox, transcript variant X2
activity dependent neuroprotector homeobox, transcript variant X5
activity dependent neuroprotector homeobox, transcript variant X6
activity dependent neuroprotector homeobox, transcript variant X4
activity dependent neuroprotector homeobox, transcript variant X3
activity dependent neuroprotector homeobox, transcript variant X7
activity-dependent neuroprotector homeobox protein isoform X3
activity-dependent neuroprotector homeobox protein isoform X1
activity-dependent neuroprotector homeobox protein isoform X2
par-6 family cell polarity regulator beta
RIPOR family member 3, transcript variant X7
RIPOR family member 3, transcript variant X3
RIPOR family member 3, transcript variant X1
RIPOR family member 3, transcript variant X6
RIPOR family member 3, transcript variant X8
RIPOR family member 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RIPOR family member 3, transcript variant X2
RIPOR family member 3, transcript variant X4
RIPOR family member 3, transcript variant X5
RIPOR family member 3, transcript variant X9
protein tyrosine phosphatase non-receptor type 1
tyrosine-protein phosphatase non-receptor type 1
ubiquitin conjugating enzyme E2 V1, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 1 isoform X2
ubiquitin conjugating enzyme E2 V1, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 1 isoform X1
snail family transcriptional repressor 1
solute carrier family 9 member A8, transcript variant X2
solute carrier family 9 member A8, transcript variant X1
beta-1,4-galactosyltransferase 5, transcript variant X1
beta-1,4-galactosyltransferase 5 isoform X1
beta-1,4-galactosyltransferase 5, transcript variant X2
beta-1,4-galactosyltransferase 5 isoform X2
potassium voltage-gated channel subfamily B member 1
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X2
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X1
somatomedin-B and thrombospondin type-1 domain-containing protein-like isoform X2
somatomedin-B and thrombospondin type-1 domain-containing protein-like isoform X1
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X3
somatomedin-B and thrombospondin type-1 domain-containing protein-like, transcript variant X4
somatomedin-B and thrombospondin type-1 domain-containing protein-like isoform X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00581
staufen double-stranded RNA binding protein 1, transcript variant X6
staufen double-stranded RNA binding protein 1, transcript variant X2
staufen double-stranded RNA binding protein 1, transcript variant X7
staufen double-stranded RNA binding protein 1, transcript variant X1
staufen double-stranded RNA binding protein 1, transcript variant X8
staufen double-stranded RNA binding protein 1, transcript variant X3
staufen double-stranded RNA binding protein 1, transcript variant X4
staufen double-stranded RNA binding protein 1, transcript variant X5
double-stranded RNA-binding protein Staufen homolog 1 isoform X7
double-stranded RNA-binding protein Staufen homolog 1 isoform X6
double-stranded RNA-binding protein Staufen homolog 1 isoform X4
double-stranded RNA-binding protein Staufen homolog 1 isoform X2
double-stranded RNA-binding protein Staufen homolog 1 isoform X3
double-stranded RNA-binding protein Staufen homolog 1 isoform X1
double-stranded RNA-binding protein Staufen homolog 1 isoform X5
chromosome segregation 1 like, transcript variant X3
chromosome segregation 1 like, transcript variant X1
chromosome segregation 1 like, transcript variant X2
ADP ribosylation factor guanine nucleotide exchange factor 2, transcript variant X2
ADP ribosylation factor guanine nucleotide exchange factor 2, transcript variant X1
brefeldin A-inhibited guanine nucleotide-exchange protein 2 isoform X2
brefeldin A-inhibited guanine nucleotide-exchange protein 2 isoform X1
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X3
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X1
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X2
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X1
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X2
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X3
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X4
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X4
uncharacterized LOC125334598, transcript variant X2
uncharacterized LOC125334598, transcript variant X1
extracellular sulfatase Sulf-2 isoform X1
extracellular sulfatase Sulf-2 isoform X2
extracellular sulfatase Sulf-2 isoform X3
extracellular sulfatase Sulf-2 isoform X4
nuclear receptor coactivator 3, transcript variant X2
nuclear receptor coactivator 3, transcript variant X1
nuclear receptor coactivator 3, transcript variant X3
nuclear receptor coactivator 3 isoform X3
nuclear receptor coactivator 3 isoform X2
nuclear receptor coactivator 3 isoform X1
nuclear receptor coactivator 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
nuclear receptor coactivator 3 isoform X4
uncharacterized PE-PGRS family protein PE_PGRS54-like